| pubmed-article:2670170 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2670170 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:2670170 | lifeskim:mentions | umls-concept:C0279781 | lld:lifeskim |
| pubmed-article:2670170 | lifeskim:mentions | umls-concept:C0677850 | lld:lifeskim |
| pubmed-article:2670170 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:2670170 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:2670170 | pubmed:dateCreated | 1989-9-29 | lld:pubmed |
| pubmed-article:2670170 | pubmed:abstractText | In response to recent advice from the US National Cancer Institute concerning the use of systemic adjuvant therapy for node-negative breast cancer we reviewed the literature and found that several studies have shown evidence of a disease-free, but not an overall, survival advantage for treated patients. The benefits have been modest and may not outweight the cost and toxic effects of such therapy. Routine use does not seem to be justified. Factors must be identified to differentiate between patients at low risk and those at high risk. It should then be determined if adjuvant therapy is truly beneficial in those who are at high risk. | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2670170 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2670170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2670170 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2670170 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:2670170 | pubmed:issn | 0820-3946 | lld:pubmed |
| pubmed-article:2670170 | pubmed:author | pubmed-author:PritchardK... | lld:pubmed |
| pubmed-article:2670170 | pubmed:author | pubmed-author:BrowmanG PGP | lld:pubmed |
| pubmed-article:2670170 | pubmed:author | pubmed-author:McCullochP... | lld:pubmed |
| pubmed-article:2670170 | pubmed:author | pubmed-author:GinsburgA DAD | lld:pubmed |
| pubmed-article:2670170 | pubmed:author | pubmed-author:PerraultD JDJ | lld:pubmed |
| pubmed-article:2670170 | pubmed:author | pubmed-author:SkillingsJJ | lld:pubmed |
| pubmed-article:2670170 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2670170 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:2670170 | pubmed:volume | 141 | lld:pubmed |
| pubmed-article:2670170 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2670170 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2670170 | pubmed:pagination | 381-7 | lld:pubmed |
| pubmed-article:2670170 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:meshHeading | pubmed-meshheading:2670170-... | lld:pubmed |
| pubmed-article:2670170 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2670170 | pubmed:articleTitle | Systemic adjuvant therapy for node-negative breast cancer. | lld:pubmed |
| pubmed-article:2670170 | pubmed:affiliation | Kingston Regional Cancer Centre, Ont. | lld:pubmed |
| pubmed-article:2670170 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2670170 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2670170 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2670170 | lld:pubmed |
